MedPath

Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Metabolic Syndrome
Interventions
Dietary Supplement: Intervention A
Dietary Supplement: Intervention B
Dietary Supplement: Intervention C
Dietary Supplement: Intervention D
Registration Number
NCT03806920
Lead Sponsor
German Institute of Human Nutrition
Brief Summary

This study evaluates the different postprandial effect of isomaltulose and sucrose on the incretin profile and as an determinant for the second meal effect.

In this nutritional intervention study, healthy participants and T2DM patients ingest 2 standardized meals for breakfast and lunch in combination with either sucrose or palatinose on 2 separate days. In addition, blood samples are taken to analyze markers of the carbohydrate metabolism, incretins and specific inflammation markers.

Detailed Description

Isomaltulose is a natural occurring disaccharide with a similar structure to sucrose. It is composed of glucose and fructose, but is linked by an α-1,6-glycosidic bond instead of α-1,2. Due to its binding, isomaltulose is slowly hydrolysed, which results in a rather weak postprandial glycemic-insulinemic response, accompanied by a minimal GIP secretion and a stimulated secretion of GLP-1. In addition, several studies have shown that the intake of foods with a low glycemic index, such as isomaltulose, tend to improve the metabolic reaction to a subsequent meal. As the exact mechanism of this "second meal effect" is still unknown, the investigators hypothesize that the modified release and action of GIP and GLP-1 are key players in regard to the described effects.Therefore, isomaltulose could be a suitable tool for reducing the risk of developing diabetes, obesity and CVD as well as improve blood glucose control in people with diabetes.

In summary, this study evaluates the different postprandial effect of isomaltulose and sucrose on the incretin profile and as a determinant for the second meal effect.

In this nutritional intervention study, healthy participants and T2DM patients ingest 2 standardized meals for breakfast and lunch in combination with either sucrose or palatinose on 2 separated days. In addition, blood samples are taken to analyze markers of the carbohydrate metabolism, incretins and specific inflammation markers.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • for T2DM patients: insulin-independent

  • for healthy subjects: at least 1 component of the metabolic syndrom:

    • Body mass index (BMI) ≥ 30 kg/m²
    • Waist-hip ratio (WHR) ≥ 85 for women and ≥ 90 for men
    • hypertension
    • dyslipidemia
    • glucose / insulin intolerance
Exclusion Criteria
  • medications: intake of medications which influence glucose metabolism
  • alcohol / drug abuse
  • physical diseases: endocrinological, malign, serious cardiovascular diseases
  • acute / chronic communicable disease
  • psychic diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Intervention AIntervention ANutritional intervention in healthy subjects and T2DM subjects: Accompanying a carbohydrate based breakfast, participants ingest either 50 g sucrose followed by a standardized lunch on 1 single day. In addition, blood samples are taken over 8 hours.
Intervention BIntervention BNutritional intervention in healthy subjects and T2DM subjects: Accompanying a carbohydrate based breakfast, participants ingest either 50 g palatinose followed by a standardized lunch on 1 single day. In addition, blood samples are taken over 8 hours.
Intervention CIntervention CNutritional intervention in healthy subjects: Accompanying a protein-based breakfast, participants ingest either 50 g sucrose followed by a standardized lunch on 1 single day. In addition, blood samples are taken over 8 hours.
Intervention DIntervention DNutritional intervention in healthy subjects: Accompanying a protein-based breakfast, participants ingest either 50 g isomaltulose followed by a standardized lunch on 1 single day. In addition, blood samples are taken over 8 hours.
Primary Outcome Measures
NameTimeMethod
disposition index4 visits, separated by 1 week each

Alteration of the Insulin secretion due to the intake of isomaltulose or sucrose in combination with different times and meal compositions. This should lead to an improved beta-cell response (Insulin secretion)

hepatic insulin extraction4 visits, separated by 1 week each

Alteration of the incretin profile due to the intake of isomaltulose or sucrose in combination with different times and meal compositions. This should lead to an improved hepatic insulin extraction (secondary effect of improved Insulin sensitivity).

insulinogenic index4 visits, separated by 1 week each

Alteration of the incretin profile due to the intake of isomaltulose or sucrose in combination with different times and meal compositions. This should lead to an improved second meal effect (Insulin sensitivity).

Secondary Outcome Measures
NameTimeMethod
incretin response4 visits, separated by 1 week each

Parameters: GIP, GLP-1, gastric emptying, Glucagon

inflammatory reaction4 visits, separated by 1 week each

Parameters: IL8, IL-18

Lipid status4 visits, separated by 1 week each

Parameters: NEFA

additional endocrine parameters4 visits, separated by 1 week each

Parameters: FGF21

Trial Locations

Locations (1)

German Institute of Human Nutrition

🇩🇪

Potsdam, Brandenburg, Germany

© Copyright 2025. All Rights Reserved by MedPath